-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Jade Biosciences, Raises Price Target to $35

Benzinga·03/25/2026 10:57:06
Listen to the news
HC Wainwright & Co. analyst Arthur He maintains Jade Biosciences (NASDAQ:JBIO) with a Buy and raises the price target from $25 to $35.